• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOG BC WING; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOG BC WING; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 382633
Medical Device Problem Code Retraction Problem (1536)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/13/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd insyte autog bc wing needle retraction is slow.The following information was provided by the initial reporter: customer states that when using item 382633, lot 4222721, there is a delay when pushing the button and the needle does not retract.Date of event: 13jan2025; occurrence number: 3.Customer does have product to return if needed.Address of facility: (b)(6) 2025 the needles had a delayed retraction.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation results: our quality engineer inspected the representative samples submitted for evaluation.Bd received 49 insyte autoguard bc 20ga 1.00 units from material number 382633, lot number 4222721.A sampling of 20 units were randomly selected for functional testing.Your reported issue of a slow retraction was confirmed and determined to be manufacturing related due to gel misplacement.A device history record review showed no non-conformances associated with this issue during the production of this batch.However, a trend has been identified for the reported failure and corrective actions have been initiated to investigate this type of incident and identity the root cause.
 
Additional Manufacturer Narrative
Additional information of fa number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE AUTOG BC WING
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key21269960
Report Number1710034-2025-00089
Device Sequence Number8090399
Product Code FOZ
UDI-Device Identifier00382903826339
UDI-Public(01)00382903826339(11)240815(17)270731(10)4222721
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
K201075
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/16/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number382633
Device Lot Number4222721
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/13/2025
Supplement Date Received by Manufacturer03/24/2025
06/13/2025
Initial Report FDA Received Date01/29/2025
Supplement Report FDA Received Date03/25/2025
06/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
MDS-25-5274
Patient Sequence Number1
Patient SexUnknown
-
-